Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2014 | 2 |
2015 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
[Prophylaxis against cytomegalovirus infection in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
Rev Chilena Infectol. 2012 Sep;29 Suppl 1:S23-8. doi: 10.4067/S0716-10182012000500004.
Rev Chilena Infectol. 2012.
PMID: 23282552
Free article.
Review.
Spanish.
The severity of the complications are mainly associated with the type of transplant and immune status against the virus of the transplant donor and the transplant recipient. It is important to prevent exposure, using safe blood transfusion CMV seronegative donors (B …
The severity of the complications are mainly associated with the type of transplant and immune status against the virus of the transplant …
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
Balcells ME, Rojas L, Le Corre N, Martínez-Valdebenito C, Ceballos ME, Ferrés M, Chang M, Vizcaya C, Mondaca S, Huete Á, Castro R, Sarmiento M, Villarroel L, Pizarro A, Ross P, Santander J, Lara B, Ferrada M, Vargas-Salas S, Beltrán-Pavez C, Soto-Rifo R, Valiente-Echeverría F, Caglevic C, Mahave M, Selman C, Gazitúa R, Briones JL, Villarroel-Espindola F, Balmaceda C, Espinoza MA, Pereira J, Nervi B.
Balcells ME, et al.
PLoS Med. 2021 Mar 3;18(3):e1003415. doi: 10.1371/journal.pmed.1003415. eCollection 2021 Mar.
PLoS Med. 2021.
PMID: 33657114
Free PMC article.
Clinical Trial.
The main limitation of this study is the lack of statistical power to detect a smaller but clinically relevant therapeutic effect of CP, as well as not having confirmed neutralizing antibodies in donor before plasma infusion. CONCLUSIONS: In the present study, we failed to …
The main limitation of this study is the lack of statistical power to detect a smaller but clinically relevant therapeutic effect of CP, as …
Item in Clipboard
One hundred years and still counting: the story of NEF--yesterday, today, and tomorrow.
Bowar-Ferres SL, Fitzpatrick ML, McClure ML.
Bowar-Ferres SL, et al.
Nurs Adm Q. 2014 Oct-Dec;38(4):332-9. doi: 10.1097/NAQ.0000000000000060.
Nurs Adm Q. 2014.
PMID: 25208153
Funds raised currently are largely from Board members, individual donors, modest foundational support, and a number of bequests. As the nursing population grows older, the potential for bequests or planned giving becomes a realistic goal. ...
Funds raised currently are largely from Board members, individual donors, modest foundational support, and a number of bequests. As t …
Item in Clipboard
A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus.
Vial PA, Valdivieso F, Calvo M, Rioseco ML, Riquelme R, Araneda A, Tomicic V, Graf J, Paredes L, Florenzano M, Bidart T, Cuiza A, Marco C, Hjelle B, Ye C, Hanfelt-Goade D, Vial C, Rivera JC, Delgado I, Mertz GJ; Hantavirus Study Group in Chile.
Vial PA, et al.
Antivir Ther. 2015;20(4):377-86. doi: 10.3851/IMP2875. Epub 2014 Oct 15.
Antivir Ther. 2015.
PMID: 25316807
Clinical Trial.
We designed an open trial to explore safety and efficacy and evaluate pharmacokinetics of immune plasma as a treatment strategy for this disease. METHODS: We performed plasmapheresis on donors at least 6 months after HCPS and measured NAb titres through a focus-reduction n …
We designed an open trial to explore safety and efficacy and evaluate pharmacokinetics of immune plasma as a treatment strategy for this dis …
Item in Clipboard
Cite
Cite